Medical data analytics company Tempus said today it has raised $110 million in a Series E financing round.
The Chicago-based company uses advanced machine learning, sequencing and AI-assisted image recognition to build medical and healthcare databases.
Funds in the round came from Bailie Gifford, accounts managed by T. Rowe Price, Revolution Growth, New Enterprise Associates and other existing investors. Funding raised will be used to expand operations into new therapeutic areas and geographies, Tempus said.
“Our mission is to help usher in precision medicine, in the United States and abroad. We couldn’t be more thrilled with our progress to date, and we’re honored to be surrounded by world class investors, collaborators, partners and an incredibly talented team here at Tempus,” founder & CEO Eric Lefkofsky said in a prepared statement.
Registration is open for DeviceTalks Boston! Join us on June 5-6, 2019, as we explore the trends and technology that are shaping the future of the medical device industry.